NVST Envista Holdings Corp
Dental Equipment & Supplies · NYSE · SEC CIK 1757073 · Fiscal year ends 12/31
Financial factors as of 2026-10-02 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.8%
TTM net income YoY4,041.2%
TTM EPS YoY4,177.8%
Revenue 3-yr CAGR3.7%
Net income 3-yr CAGR49.2%
Margins
Gross margin55.9%
Operating margin25.4%
Net margin22.0%
FCF margin8.4%
EBITDA margin29.3%
Returns
ROE20.5%
ROA11.3%
ROIC (approx.)20.0%
Asset turnover0.51x
Leverage & solvency
Liabilities / assets45.0%
Debt / equity0.46x
Current ratio2.45x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.48x
Accruals ratio5.9%
Payout ratio—
Capex / revenue2.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2.72B | $2.51B | $2.57B | $2.57B | $2.51B |
| Cost of revenue | $1.23B | $1.14B | $1.13B | $1.09B | $1.08B |
| Gross profit | $1.49B | $1.37B | $1.44B | $1.47B | $1.43B |
| R&D expense | $114.00M | $99.10M | $93.80M | $100.10M | $100.50M |
| SG&A expense | $1.16B | $1.16B | $1.06B | $1.06B | $1.02B |
| Operating income | $216.10M | -$1.04B | $31.50M | $319.20M | $306.20M |
| Interest expense | — | — | $63.40M | $38.40M | $54.10M |
| Pretax income | $177.20M | -$1.08B | -$54.90M | $283.90M | $254.50M |
| Income tax | $130.20M | $33.90M | $45.30M | $45.90M | -$9.00M |
| Net income | $47.00M | -$1.12B | -$100.20M | $243.10M | $340.50M |
| EBITDA | $332.10M | -$915.10M | $167.10M | $457.00M | $424.00M |
| EPS (basic) | 0.28 | -6.50 | -0.60 | 1.49 | 2.11 |
| EPS (diluted) | 0.28 | -6.50 | -0.60 | 1.37 | 1.92 |
| Weighted avg. shares (diluted) | 169.20M | 172.20M | 166.90M | 177.60M | 177.60M |
| Balance sheet | |||||
| Cash & equivalents | $1.21B | $1.07B | $940.00M | $606.90M | $1.07B |
| Receivables | $429.60M | $363.00M | $407.50M | $393.50M | $331.90M |
| Inventory | $288.10M | $241.00M | $258.80M | $300.80M | $263.80M |
| Current assets | $2.03B | $1.79B | $1.74B | $1.42B | $1.84B |
| PP&E, net | $296.80M | $277.00M | $309.60M | $293.60M | $264.10M |
| Goodwill | $2.36B | $2.26B | $3.29B | $3.50B | $3.13B |
| Intangibles | $627.20M | $649.90M | $954.00M | $1.09B | $1.05B |
| Total assets | $5.68B | $5.35B | $6.61B | $6.59B | $6.57B |
| Current liabilities | $852.60M | $878.70M | $780.80M | $1.24B | $1.21B |
| Short-term debt | $0 | $116.00M | $115.30M | $510.00M | $432.40M |
| Long-term debt | $1.45B | $1.28B | $1.40B | $870.70M | $883.40M |
| Total debt | $1.45B | $1.39B | $1.51B | $1.38B | $1.32B |
| Total liabilities | $2.57B | $2.42B | $2.43B | $2.38B | $2.52B |
| Shareholders' equity | $3.11B | $2.93B | $4.17B | $4.21B | $4.06B |
| Net debt | $236.60M | $325.20M | $573.40M | $773.80M | $242.20M |
| Shares outstanding | 163.80M | 172.20M | 171.50M | 163.20M | 161.60M |
| Cash flow statement | |||||
| Operating cash flow | $275.70M | $336.50M | $275.70M | $182.70M | $361.60M |
| Capital expenditure | $45.30M | $33.80M | $58.20M | $75.70M | $54.70M |
| Free cash flow | $230.40M | $302.70M | $217.50M | $107.00M | $306.90M |
| Investing cash flow | -$51.10M | -$54.60M | -$62.40M | -$657.30M | $262.70M |
| Financing cash flow | -$170.90M | -$103.70M | $118.90M | $12.50M | -$465.60M |
| Depreciation & amortization | $116.00M | $123.10M | $135.60M | $137.80M | $117.80M |
| Stock-based compensation | $37.60M | $35.30M | $30.70M | $30.50M | $28.20M |
Free plan shows the latest 5 periods; Pro shows all 9 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.